Occurrence of an SME-2-producing Serratia marcescens isolate in Canada
Authors:
- Amélie CarrërACAmélie Carrër
- Laurent PoirelLPLaurent Poirel
- Johann D. PitoutJPJohann D. Pitout
- Deirdre ChurchDCDeirdre Church
- Patrice NordmannPNPatrice Nordmann
- 1 February 2008
- journal article
- other
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 31 (2) , 181-182
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- SME-2-Producing Serratia marcescens Isolate from SwitzerlandAntimicrobial Agents and Chemotherapy, 2007
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- SME-Type Carbapenem-Hydrolyzing Class A β-Lactamases from Geographically Diverse Serratia marcescens StrainsAntimicrobial Agents and Chemotherapy, 2000
- Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing beta-lactamase Sme-1, and comparison of this regulator with other beta-lactamase regulatorsAntimicrobial Agents and Chemotherapy, 1995
- Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6Antimicrobial Agents and Chemotherapy, 1994
- Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria.Proceedings of the National Academy of Sciences, 1993